Methods: We searched PubMed using the terms topical, antiandrogen, hormonal, clascoterone, spironolactone, and acne vulgaris. Results: The majority of articles identified related to clascoterone and topical spironolactone
This highlights differences in baseline risk and potential effect modification by concurrent therapy [1, 2, 7]
de Almada CN, et al
The Medicare GLP-1 Bridge (launching July 1, 2026) provides weight-loss access at $50/month outside Part D for eligible beneficiaries verify Bridge eligibility with your prescriber
J Pathol 228(3):378390 Roudnicky F et al (2013) Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis
These predispositions should be interpreted with a qualified healthcare provider as one factor among clinical history, comorbidities, and medication tolerability